Nirmala Bhoo Pathy: I’m over the moon to be featured in Tatler Asia

Ophira Ginsburg shared a post by Nirmala Bhoo Pathy, on LinkedIn, adding:

”Amaaaazing! What a role model you are, dear Nirmala!!”

Quoting Nirmala Bhoo Pathy’s post:

”I’m over the moon to be featured in Tatler Asia!

As someone deeply committed to understanding and addressing how cancer impacts women, it’s an honor to have both my work and our Lancet Commission on Women, Power and Cancer recognized.

Thanks Tania Jayatilaka for the amazing write-up. The feature perfectly captures the essence of my journey and our collective mission to drive true equity in healthcare.

‘At the end of the day, feminism isn’t about saying that women are better than men nor is it men versus women. It’s about women for everyone. Of course, it starts with women. But we also know that when we start with the women, the ripple effect will go to entire families and end up benefiting the whole of society.”’

Source: Ophira Ginsburg/LinkedIn and Nirmala Bhoo Pathy/LinkedIn

Ophira Ginsburg is a Canadian medical oncologist, humanitarian, and global cancer advocate. Currently, she is the Senior Scientific Officer and Senior Advisor for Clinical Research at the US NCI’s Center for Global Health. Formerly based at the University of Toronto, Canada, she was a Medical Officer at the World Health Organization (WHO) Headquarters in Geneva, Switzerland, and has served as an ad hoc consultant to several UN agencies. She is the co-chair of The Lancet Commission on Women and Cancer. In 2022, Dr. Ginsburg won the American Society of Clinical Oncology’s Humanitarian Award.

Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia.

She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).